Results 41 to 50 of about 1,124,319 (216)

Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway

Tumor Biology, 2017
Gallbladder cancer has poor prognosis and limited therapeutic options. Arctigenin, a representative dibenzylbutyrolactone lignan, occurs in a variety of plants.
Mingdi Zhang, Shizhong Cai, Bin Zuo, Wei Gong, Zhaohui Tang, Di Zhou, Mingzhe Weng, Yiyu Qin, Shouhua Wang, Jun Liu, Fei Ma, Zhiwei Quan   +11 more
doaj   +1 more source

Heterochrony as Diachronically Modified Cell-Cell Interactions

Biology, 2016
Heterochrony is an enabling concept in evolution theory that metaphorically captures the mechanism of biologic change due to mechanisms of growth and development.
John S. Torday
doaj   +1 more source

Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer

Contemporary Oncology, 2022
Shinichiro Okauchi, Kunihiko Miyazaki, Hiroaki Satoh   +2 more
doaj   +1 more source

Thematic Review Series: Sphingolipids. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling*1

Journal of Lipid Research, 2008
Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates a wide array of biologic effects through its interaction with a family of five G protein-coupled receptors.
Deborah A. Lebman, Sarah Spiegel
doaj   +1 more source

Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling

Tumor Biology, 2017
Recent research indicates that the C-terminal Eps15 homology domain 1 is associated with epithelial growth factor receptor–mediated endocytosis recycling in non-small-cell lung cancer.
Dandan Tong, Ya-Nan Liang, AA Stepanova, Yu Liu, Xiaobo Li, Letian Wang, Fengmin Zhang, NV Vasilyeva   +7 more
doaj   +1 more source

Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance

Frontiers in Oncology
Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are highly effective against tumors harboring the T790M mutation.
Wanming He, Lihua Tong, Wen Yang, Yanling Yuan, Yu Li, Wubing Tang   +5 more
doaj   +1 more source

Thematic Review Series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a*

Journal of Lipid Research, 2008
Gangliosides are sialic acid-containing glycosphingolipids that have long been associated with tumor malignancy and metastasis. Mounting evidence suggests that gangliosides also modulate tumor angiogenesis.
Purna Mukherjee, Anthony C. Faber, Laura M. Shelton, Rena C. Baek, Thomas C. Chiles, Thomas N. Seyfried   +5 more
doaj   +1 more source

THE EFFECTS OF NITROUS OXIDE ON VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND ITS SOLUBLE RECEPTOR 1 (VEGFR1) IN PATIENT UNDERGOING UROLOGICAL SURGERY [PDF]

, 1969
Yasemin Hakimoglu, Murat Can, Sedat Hakimoğlu, Ayca Gorkem Mungan, Şereften Açıkgöz, Nuran Cıkcıkoğlu Yıldırım, Necmettin Aydin Mungan, Işıl Özkoçak Turan   +7 more
openalex   +1 more source

Specific radiolabeling of a cell surface receptor for epidermal growth factor. [PDF]

, 1977
M Das, Tokichi Miyakawa, Colin Fox, Rebecca M. Pruss, Aharon Aharonov, Harvey R. Herschman   +5 more
openalex   +1 more source

Molecular mechanism of mitogen action: Processing of receptor induced by epidermal growth factor [PDF]

, 1979

openalex   +1 more source